Federal health officials have declined to approve the psychedelic drug MDMA as a therapy for PTSD. Drugmaker Lykos ...

Lykos Therapeutics filed an application for FDA approval of its version of MDMA-assisted therapy for PTSD in February 2024.

The US Food and Drug Administration's (FDA) decision not to approve midomafetamine-assisted therapy (MDMA-AT) for ...

Critics addressed the elephant in the room during the FDA’s first public meeting on trauma since its decision to delay ...

The U.S. Food and Drug Administration (FDA) has issued a complete response letter for MDMA-assisted psychotherapy (MDMA-AT) ...

In a previous blog on the use of psychedelics to treat mental health disorders, we reported that the US Food and Drug Administration (FDA) ...

The FDA rejected MDMA therapy as a treatment for PTSD, with the advisory committee saying there is not enough evidence it was safe or effective. A setback to the use of psychedelics for the treatment ...

The post A Setback for MDMA-Assisted Psychotherapy appeared first on Reason.com. Autoblog chats to a hardcore Mustang fan and ...

A Boulder-based therapist characterized the decision as an enormous setback for those seeking treatment for PTSD.

Delve into the psychedelic-assisted therapy market and investors' sentiment after the FDA's decision about Lykos' MDMA ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Amy Emerson is stepping down on the heels of the FDA last month rejecting Lykos Therapeutics’ MDMA-based therapy for ...